Healthcare Transition in Inherited Metabolic Disorders—Is a Collaborative Approach between US and European Centers Possible?

Inherited metabolic diseases (IMDs) are rare heterogenous genetic conditions. Advanced technology and novel therapeutic developments have led to the improved life expectancy of patients with IMDs. Long-term, they require close surveillance from specialist adult metabolic providers. Healthcare transi...

Full description

Bibliographic Details
Main Authors: Jessica I. Gold, Karolina M. Stepien
Format: Article
Language:English
Published: MDPI AG 2022-09-01
Series:Journal of Clinical Medicine
Subjects:
Online Access:https://www.mdpi.com/2077-0383/11/19/5805
_version_ 1797478587702444032
author Jessica I. Gold
Karolina M. Stepien
author_facet Jessica I. Gold
Karolina M. Stepien
author_sort Jessica I. Gold
collection DOAJ
description Inherited metabolic diseases (IMDs) are rare heterogenous genetic conditions. Advanced technology and novel therapeutic developments have led to the improved life expectancy of patients with IMDs. Long-term, they require close surveillance from specialist adult metabolic providers. Healthcare transition (HCT) is the planned, purposeful process of preparing adolescents for adult-centered medical care and has been recognized globally as a necessary component of care for IMDs. Two recent surveys outlined barriers to the HCT in the US and the UK. The limited knowledge of IMDs among adult physicians was one of the barriers. Some work on specialty curriculum has started and aims to improve the structured training and awareness of rare diseases. Other barriers included social and legal aspects of adulthood, social, vocational and educational support for young adults, care fragmentation and insurance coverage. Although various HCT tools are available, they cannot always be standardized for IMDs. Despite the remarkable differences in the healthcare systems and physicians’ training, collaboration among metabolic centers is possible. International rare disease alliance may enhance the patients’ management via guidelines development and standardized training for adult metabolic providers.
first_indexed 2024-03-09T21:33:58Z
format Article
id doaj.art-fe44dcc6116f4be29c0a5f482a5bf000
institution Directory Open Access Journal
issn 2077-0383
language English
last_indexed 2024-03-09T21:33:58Z
publishDate 2022-09-01
publisher MDPI AG
record_format Article
series Journal of Clinical Medicine
spelling doaj.art-fe44dcc6116f4be29c0a5f482a5bf0002023-11-23T20:49:03ZengMDPI AGJournal of Clinical Medicine2077-03832022-09-011119580510.3390/jcm11195805Healthcare Transition in Inherited Metabolic Disorders—Is a Collaborative Approach between US and European Centers Possible?Jessica I. Gold0Karolina M. Stepien1Division of Human Genetics, Children’s Hospital of Philadelphia, Philadelphia, PA 19104, USAInherited Metabolic Disorders Department, Salford Royal NHS Foundation Trust, Salford H6 8HD, UKInherited metabolic diseases (IMDs) are rare heterogenous genetic conditions. Advanced technology and novel therapeutic developments have led to the improved life expectancy of patients with IMDs. Long-term, they require close surveillance from specialist adult metabolic providers. Healthcare transition (HCT) is the planned, purposeful process of preparing adolescents for adult-centered medical care and has been recognized globally as a necessary component of care for IMDs. Two recent surveys outlined barriers to the HCT in the US and the UK. The limited knowledge of IMDs among adult physicians was one of the barriers. Some work on specialty curriculum has started and aims to improve the structured training and awareness of rare diseases. Other barriers included social and legal aspects of adulthood, social, vocational and educational support for young adults, care fragmentation and insurance coverage. Although various HCT tools are available, they cannot always be standardized for IMDs. Despite the remarkable differences in the healthcare systems and physicians’ training, collaboration among metabolic centers is possible. International rare disease alliance may enhance the patients’ management via guidelines development and standardized training for adult metabolic providers.https://www.mdpi.com/2077-0383/11/19/5805transition serviceadult metabolic medicinecollaborationchallengesinherited metabolic diseaseshealthcare systems
spellingShingle Jessica I. Gold
Karolina M. Stepien
Healthcare Transition in Inherited Metabolic Disorders—Is a Collaborative Approach between US and European Centers Possible?
Journal of Clinical Medicine
transition service
adult metabolic medicine
collaboration
challenges
inherited metabolic diseases
healthcare systems
title Healthcare Transition in Inherited Metabolic Disorders—Is a Collaborative Approach between US and European Centers Possible?
title_full Healthcare Transition in Inherited Metabolic Disorders—Is a Collaborative Approach between US and European Centers Possible?
title_fullStr Healthcare Transition in Inherited Metabolic Disorders—Is a Collaborative Approach between US and European Centers Possible?
title_full_unstemmed Healthcare Transition in Inherited Metabolic Disorders—Is a Collaborative Approach between US and European Centers Possible?
title_short Healthcare Transition in Inherited Metabolic Disorders—Is a Collaborative Approach between US and European Centers Possible?
title_sort healthcare transition in inherited metabolic disorders is a collaborative approach between us and european centers possible
topic transition service
adult metabolic medicine
collaboration
challenges
inherited metabolic diseases
healthcare systems
url https://www.mdpi.com/2077-0383/11/19/5805
work_keys_str_mv AT jessicaigold healthcaretransitionininheritedmetabolicdisordersisacollaborativeapproachbetweenusandeuropeancenterspossible
AT karolinamstepien healthcaretransitionininheritedmetabolicdisordersisacollaborativeapproachbetweenusandeuropeancenterspossible